A review published in Alimentary Pharmacology and Therapeutics showed alcohol consumption adversely altered gut microbiota and could lead to negative impacts on the liver. It is well known that alcohol intake directly and adversely affects the liver, but more recently, it has also been clinically shown to impact the gastrointestinal microbiota. To better elucidate this relationship the authors utilized the PubMed data base, to identify and review data from research articles addressing this topic. The studies that the authors identified showed alcohol…

by Bianca Garilli, ND An article published in the New England Journal of Medicine  reviewed data collected from 1998-2012 from adults in the Swedish National Diabetes Register with type 1 diabetes (T1D) and type 2 diabetes (T2D).  Information was analyzed for various end points including overall mortality rate and incidence of cardiovascular disease (CVD) and coronary heart disease (CHD). Results from the study showed that during the observed time period the incidence rates of CVD and overall mortality rates decreased in both…

This video series is from conversations with Charles Serhan, PhD, DSc, during the recent 15th International Conference on Bioactive Lipids in Cancer, Inflammation and Related Diseases held Oct. 22-24, 2017 in Puerto Vallarta, Mexico. In this quick video, Dr. Serhan discusses ongoing research centers that are conducting research to assess SPMs efficacy in a variety of health conditions, as well as revealing additional human tissues where SPMs have been found. Charles Serhan, PhD, DSc is Director of the Center for…

by Bianca Garilli, ND The World Health Organization (WHO) estimates the total number of people living with diabetes in 2014 was 422 million, equal to approximately 8.5% of adults worldwide– a majority of whom were diagnosed with type 2 diabetes (T2D). These figures are a staggering increase from the estimated 108 million people, globally, who were diagnosed with diabetes in 1980!1 The United States does not fare any better.  According to the Centers for Disease Control and Prevention, 29.1 million people…

Patients with diabetes often have numerous comorbid conditions such as obesity, heart disease, kidney disease and hypertension to name a few. Hypertension or high blood pressure (BP), in particular, can lead to increased risks for atherosclerotic cardiovascular disease (ASCVD), heart failure (HF) and attendant microvascular complications. The last time the American Diabetes Association (ADA) provided a position statement on hypertension was more than 15 years ago. Given the increasing rise in the numbers of people afflicted by diabetes, increased BMI…

This presentation, entitled, “Probiotics: From Basic Science to Clinical Application” was delivered by Eamon M Quigley, MD at the ASPEN Symposium in February 2015. Dr. Quigley is the Chief of the Division of Gastroenterology and Hepatology at Houston Methodist Hospital in Texas. His presentation begins with a definition of probiotics and discussion of the health benefits they can have on the body. Current clinical applications for probiotics include diarrheal illnesses, necrotizing enterocolitis, inflammatory bowel disease, irritable bowel syndrome, and liver…

A recent article  published in a recent edition of Preventing Chronic Disease: Public Health Research, Practice and Policy proposes a shift from discussing BMI and weight loss with patients in the provider’s office, to focusing on the topics of awareness and education surrounding healthy life habits, physical activity in particular.  Authors Emily Dollar and team encourage an emphasis on cardiorespiratory fitness over body size to minimize the risk of stigma associated with overweight and obesity and increase collaboration between patient and provider.…

The mornings are brisk and the sun is setting earlier- it’s definitely fall out there. With the seasonal change also comes a change in the local produce that is available. The markets start to fill with apples, pears, pumpkins, acorn squash, brussels sprouts, cauliflower, broccoli and other delightful fall produce. While we will miss the high levels of antioxidants present in fresh berries and cherries that are now not easily available, this season’s produce offerings still have lots of health…

A 2009 publication, obesity-induced insulin resistance and hepatic steatosis are alleviated by omega-3 fatty acids: a role for resolvins and protectins can be downloaded here. In this paper, the authors discuss omega-3-polyunsaturated fatty acids (omega-3-PUFAs), which have well-documented protective effects that are attributed not only to eicosanoid inhibition but also to the formation of novel biologically active lipid mediators (i.e., resolvins and protectins). In this study, we examined their effects on ob/ob mice, an obesity model of insulin resistance and…

Novel Pro-Resolving Mediators and Mechanisms in Inflammation presented by Jesmond Dalli, PhD for ASPEN Clinical Nutrition Week 2015 This presentation, entitled Novel Pro-Resolving Mediators and Mechanisms in Inflammation: Immunoresolvents is delivered by Dr. Jesmond Dalli and Dr. Charles N. Serhan. They are preeminent researchers in the field of inflammation resolution and share their insights at ASPEN 2015. They have recently published some of their findings on inflammation resolution along with the mechanisms they have uncovered regarding inflammation. The talk focuses…